Zobrazeno 1 - 3
of 3
pro vyhledávání: '"F F, Fassos"'
Autor:
A F, Collins, F F, Fassos, S, Stobie, N, Lewis, D, Shaw, M, Fry, D M, Templeton, R A, McClelland, G, Koren, N F, Olivieri
Publikováno v:
Blood. 83:2329-2333
Several life-threatening complications of the common disorder sickle cell disease require management with red blood cell transfusions and, hence, long-term iron-chelating therapy. The efficacy of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e6f779446ea90dd8643d264bb96a75
https://doi.org/10.1182/blood.v83.8.2329.bloodjournal8382329
https://doi.org/10.1182/blood.v83.8.2329.bloodjournal8382329
Publikováno v:
International journal of clinical pharmacology and therapeutics. 34(7)
Recently, we demonstrated that administration of the orally active iron chelating agent deferiprone (1,2-dimethyl-3-hydroxypyrid-4-one (L1)) at 6-hour intervals results in significantly greater urinary iron excretion than that induced during administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7fd873d80c96bb5470d1ec941bc08a5f
https://pubmed.ncbi.nlm.nih.gov/8832304
https://pubmed.ncbi.nlm.nih.gov/8832304
Autor:
Pope E; Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada., Berkovitch M, Klein J, Fassos F, Koren G
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 1997 Feb; Vol. 19 (1), pp. 95-7.